Evaluation of Investigations Suitable To Stop Treatment in Spinal Tuberculosis
Journal of Clinical Orthopaedics | Vol 9 | Issue 2 | July-December 2024 | page: 11-16 | Vishal Kumar, Parth Bansal, Sarvdeep Singh Dhatt, Tensubam Tomthin Meetei, Arvind Vatkar, Sachin Kale
DOI: https://doi.org/10.13107/jcorth.2024.v09i02.646
Author: Vishal Kumar [1], Parth Bansal [1], Sarvdeep Singh Dhatt [1], Tensubam Tomthin Meetei [1], Arvind Vatkar [2], Sachin Kale [3]
[1] Department of Orthopaedics, PGIMER, Chandigarh, India
[2] Orthopaedics Department, Fortis Hiranandani Hospital, Vashi, Apollo Hospital, Navi Mumbai, Belapur, Maharashtra, India.
[3] Department of Orthopaedics, D.Y Patil School of Medicine and Hospital, Nerul, Navi Mumbai, Maharashtra, India.
Address of Correspondence
Dr. Arvind Vatkar,
Department of Orthopaedics, MGM Medical college, Nerul, Navi Mumbai, Maharashtra, India.
E-mail: vatkararvind@gmail.com
Abstract
Spinal tuberculosis is the most common extrapulmonary manifestation of tuberculosis and accounts for half of the cases of skeletal tuberculosis and 2% of all tuberculosis cases. The prevalence of spinal tuberculosis is widespread in an endemic county such as India where many people live under poor socioeconomic demographics. It is still a major cause of morbidity and economic loss as it generally affects the productive age groups and the deformities of spinal tuberculosis can have long-lasting effects on the affected population. Detection of drug-resistant strains is another worrying factor that contributes to the reemergence of spinal tuberculosis as a major cause of concern as it can lead to prolonged treatment and failure if not properly addressed on time. There is no proper gold standard investigation to reliably detect the endpoint of treatment in spinal tuberculosis and there is a lack of consensus regarding the exact duration of antitubercular therapy. This remains a gray area even today. This review article aims to look into some of the investigations that can help determine the endpoint of treatment with a special focus on magnetic resonance imaging (MRI) and positron emission tomography scan (MRI scan).
Keywords: Spinal tuberculosis, magnetic resonance imaging scan, positron emission tomography scan
References
1. Misra UK, Warrier S, Kalita J, Kumar S. Spinal neuroradiology MRI findings in Pott’s spine and correlating clinical progress with radiological findings. Neuroradiology 2020;62:825-32.
2. Jain AK, Rajasekaran S, Jaggi KR, Myneedu VP. Tuberculosis of the spine. J Bone Joint Surg Am 2020;102:617-28.
3. Sharma SK, Ryan H, Khaparde S, Sachdeva KS, Singh AD, Mohan A, et al. Index-TB guidelines: Guidelines on extrapulmonary tuberculosis for India. Indian J Med Res 2017;145:448-63.
4. Ansari S, Amanullah M, Ahmad K, Rauniyar RK. Pott’s spine: Diagnostic imaging modalities and technology advancements. N Am J Med Sci 2013;5:404-11.
5. Skoura E, Zumla A, Bomanji J. Imaging in tuberculosis. Int J Infect Dis 2015;32:87-93.
6. Rajasekaran S, Soundararajan DC, Shetty AP, Kanna RM. Spinal tuberculosis: Current concepts. Glob Spine J 2018;8(4 suppl):96S-108.
7. Garg RK, Somvanshi DS. Spinal tuberculosis: A review. J Spinal Cord Med 2011;34:440-54.
8. Currie S, Galea-soler S, Barron D, Chandramohan M, Groves C. MRI characteristics of tuberculous spondylitis. Clin Radiol 2011;66:778-87.
9. Jain AK, Sreenivasan R. Magnetic resonance evaluation of tubercular lesion in spine. Int Orthop 2012;36:261-9.
10. Rivas-Garcia A, Sarria-Estrada S, Torrents-Odin C, Casas-Gomila L, Franquet E. Imaging findings of Pott’s disease. Eur Spine J 2013;22 (Suppl 4):567-78.
11. Lee IS, Lee JS, Kim SJ, Jun S, Suh KT. Fluorine-18-fluorodeoxyglucose positron emission tomography/computed tomography imaging in pyogenic and tuberculous spondylitis: Preliminary study. J Comput Assist Tomogr 2009;33:587-92.
12. Kimizuka Y, Ishii M, Murakami K, Ishioka K, Yagi K, Ishii K, et al. A case of skeletal tuberculosis and psoas abscess: Disease activity evaluated using F-fluorodeoxyglucose positron emission tomography-computed tomography. BMC Med Imaging 2013;13:37.
13. Vorster M, Sathekge MM, Bomanji J. Advances in imaging of tuberculosis: the role of 18F-FDG PET and PET/CT. Curr Opin Pulm Med 2014;20:287-93.
14. Index TB Guidelines. Guidelines on Extra-pulmonary Tuberculosis for India. World Health Organization; 2016.
15. Mittal S, Jain AK, Chakraborti KL, Aggarwal AN, Upreti L, Bhayana H. Evaluation of healed status in tuberculosis of spine by fluorodeoxyglucose-positron emission tomography/computed tomography and contrast magnetic resonance imaging. Indian J Orthop 2019;53:160-8.
16. Dureja S, Sen IB, Acharya S. Potential role of F18 FDG PET-CT as an imaging biomarker for the noninvasive evaluation in uncomplicated skeletal tuberculosis: A prospective clinical observational study. Eur Spine J 2014;23:2449-54.
17. Kim SJ, Kim IJ, Suh KT, Kim YK, Lee JS. Prediction of residual disease of spine infection using F-18 FDG PET/CT. Spine 2009;34:2424-30.
18. Fuster D, Tomás X, Mayoral M, Soriano A, Manchón F, Cardenal C, et al. Prospective comparison of whole-body 18 F-FDG PET/CT and MRI of the spine in the diagnosis of haematogenous spondylodiscitis. Eur J Nucl Med Mol Imaging 2015;42:264-71.
19. Jain TK, Sood A, Basher RK, Battacharya A, Mittal BR, Aggarwal AK. “Pine tree” appearance on 18F-FDG PET/CT MIP image in spinal tuberculosis. Rev Esp Med Nucl Image Mol 2017;36:122-3.
20. Bassetti M, Merelli M, Di Gregorio F, Siega PD, Screm M, Scarparo C, et al. Higher fluorine-18 fluorodeoxyglucose positron emission tomography (FDG-PET) uptake in tuberculous compared to bacterial spondylodiscitis. Skeletal Radiol 2017;46:777-83.
21. Liu W, Li X, Yin J, Li X, Wang X. Diagnostic value of (18) F-FDG PET/CT in extrapulmonary tuberculosis. J South Med Univ 2013;33:1083.
22. Jeon I, Kong E, Kim SW. Simultaneous 18F-FDG PET/MRI in tuberculous spondylitis: Independent method for assessing therapeutic response – case series. BMC Infect Dis 2019;19:845.
| How to Cite this article: Kumar V, Bansal P, Dhatt SS, Meetei TT, Vatkar A, Kale S. Evaluation of Investigations Suitable To Stop Treatment in Spinal Tuberculosis. Journal of Clinical Orthopaedics July-December 2024;9(2):11-16. |
(Article Text HTML) (Download PDF)
